Choroid Plexus Enlargement is Associated with Disease Severity and Elevated White Matter Myo -inositol in Progressive Multiple Sclerosis
Abstract
Introduction: Choroid plexus (CP) enlargement on brain MRI has been identified as an emerging neuroinflammatory biomarker in multiple sclerosis (MS), yet its relationship to downstream parenchymal neurochemical abnormalities remains unknown. Proton magnetic resonance spectroscopy ( 1 H MRS) enables non-invasive in vivo quantification of neurometabolites, making it well-suited to probe downstream consequences of CP pathology in MS.
Methods: Ultra-high-field 7T 1 H MRS was performed in 45 people with MS (pwMS) (28 Relapsing Remitting MS, RRMS; 17 Progressive MS, PMS) and 43 age- and sex-matched healthy controls (HCs) in the posterior cingulate cortex (PCC) and centrum semiovale white matter (CSWM). CP volume, EDSS, and MS Functional Composite measures were also acquired. Group differences in metabolite concentrations were evaluated using Mann-Whitney U tests with correction for multiple comparisons, and associations between CP volume, altered metabolites, and clinical disability and functional measures were investigated.
Results: Myo -inositol (mI) was significantly elevated and total N- acetylaspartate was reduced in both MS subtypes, in the CSWM. In PMS, CP volume was positively associated with CSWM mI/total creatine (tCr) (ρ = 0.63, p = 0.008), an association absent in RRMS. Across the combined MS cohort, CP volume correlated significantly with EDSS (ρ = 0.40, p = 0.006).
Conclusions: WM mI/tCr was elevated and tNAA/tCr was reduced across MS phenotypes compared with…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 45 participants or records.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.